Portfolio Update

RNS Number : 0339Y

Intl. Biotechnology Trust PLC

16 August 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 July 2018

Net Assets	£251m
Net Assets per share	670p
Share price	668p
Total value of unquoted investments	£28m
Total number of portfolio companies	74
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Celgene	6.9
Illumina	5.1
Vertex	4.4
Genmab	3.9
Exelixis	3.7
Regeneron	3.5
Morphosys	3.4
Alexion	3.3
Neurocrine	3.3
Array	3.2
	-----------
Total	40.7

Geographical Allocation	% NAV
US & Canada	86
Europe	14
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	89
Unquoted	11
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	35
Mid Cap =USD1-10BN	41
Small Cap <USD1BN	24
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	47
CNS	13
Rare diseases	14
Ophthalmology	7
Infectious Diseases	3
Inflammation	2
Metabolic	2
Medtech	2
Other	10
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

16 AUGUST 2018

 

END

 

 

PFUBGGDIBGBBGIL